Form CERTNAS - Certification by the Nasdaq Stock Market approving securities for listing:
SEC Accession No. 9999999997-16-024373
Filing Date
2016-07-11
Accepted
2016-07-11 16:35:23
Documents
1
Effectiveness Date
2016-07-11

Document Format Files

Seq Description Document Type Size
1 AUTO-GENERATED PAPER DOCUMENT 9999999997-16-024373.paper CERTNAS 294
  Scanned paper document scanned.pdf   31293
  Complete submission text file 9999999997-16-024373.txt   1394
Mailing Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (604) 629-5989
DelMar Pharmaceuticals, Inc. (Filer) CIK: 0001498382 (see all company filings)

EIN.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: CERTNAS | Act: 34 | File No.: 001-37823 | Film No.: 16004310
SIC: 2834 Pharmaceutical Preparations